Ares Management Corp (ARES) Technical Analysis
$128.25▲4.12%
Insights
- Ares Management is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ares Management stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Ares Management stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Ares Management stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 60.25 | Sell |
Stochastic | 78.13, 84.33 | Neutral |
Ultimate Oscillator | 52.29 | Neutral |
Stochastic Relative Strength Index | 84.73, 91.06 | Sell |
Moving Average Convergence Divergence | 3.37, 2.56 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 121.17 | Buy |
20 | 118.99 | Buy |
50 | 111.49 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 121.76 | Buy |
20 | 118.72 | Buy |
50 | 118.65 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 120.96 | Buy |
20 | 119.17 | Buy |
50 | 110.35 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 125.07 | Buy |
20 | 123.03 | Buy |
50 | 111.25 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 125.46 | Sell |
20 | 126.19 | Buy |
50 | 117.82 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 131.36 |
Resistance L2 | 129.36 |
Resistance L1 | 126.99 |
Pivot Point | 124.99 |
Support L1 | 122.62 |
Support L2 | 120.62 |
Support L3 | 118.25 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.